US Stock MarketDetailed Quotes

THAR Tharimmune

Watchlist
  • 1.200
  • -0.005-0.42%
Close Apr 25 16:00 ET
  • 1.090
  • -0.110-9.17%
Pre 08:42 ET
2.53MMarket Cap-0.13P/E (TTM)

About Tharimmune Company

Tharimmune, Inc. is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology. It also develops TH104, which is known to suppress chronic, debilitating pruritus or \"uncontrollable itching\" in PBC, a rare and orphan liver disease with no known cure. The company was founded on March 28, 2017 and is headquartered in Bridgewater, NJ.

Company Profile

SymbolTHAR
Company NameTharimmune
Listing DateJan 12, 2022
Founded2017
CEOMr. Randy Milby
MarketNASDAQ
Employees3
Fiscal Year Ends12-31
Address1200 Route 22 East,Suite 2000
CityBridgewater
ProvinceNew Jersey
CountryUnited States of America
Zip Code08807
Phone1-908-955-3140

Company Executives

  • Name
  • Position
  • Salary
  • Randy Milby
  • Chief Executive Officer and Chairman of the Board
  • 742.42K
  • Dong Kim
  • Chief Financial Officer
  • --
  • Sireesh Appajosyula
  • Director and Chief Operating Officer
  • 8.48K
  • Sanam Parikh
  • Director
  • --
  • Vincent LoPriore
  • Director
  • --
  • Kelly J. Anderson
  • Independent Director
  • 46.17K
  • Leonard L. Mazur
  • Independent Director
  • 34.43K
  • Dr. Lynne A. Bui, M.D.
  • Independent Director
  • 41.57K

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More